**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 7681-82-5 |Sodium Iodide | >99 | 231-679-3 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Air sensitive.Moisture sensitive.Light sensitive.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and
diarrhea. Chronic ingestion of iodides during pregnancy has resulted
in fetal death, severe goiter, and cretinoid appearance of the
newborn.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Prolonged or repeated exposure may cause adverse reproductive
effects. Chronic exposure can lead to iodism characterized by
salivation, nasal discharge, sneezing, conjunctivitis, fever,
laryngitis, bronchitis, stomatitis, and skin rashes. Adverse
reproductive effects have been reported in animals.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Flush skin with plenty of water for at least 15 minutes while
removing contaminated clothing and shoes. Get medical aid if
irritation develops or persists. Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid if cough or other symptoms appear.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use
extinguishing media appropriate to the surrounding fire. Substance is
noncombustible.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire. Do NOT get water inside containers.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation. Place under an inert atmosphere. Do not get
water inside containers.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid
contact with eyes, skin, and clothing. Avoid ingestion and
inhalation. Store protected from light. Handle under an inert
atmosphere. Store protected from air. Do not allow contact with
water. Keep from contact with moist air and steam.
Storage:
Store in a cool place in the original container and protect from
sunlight. Do not store in direct sunlight. Store in a tightly closed
container. Do not expose to air. Store protected from moisture.
Store protected from light. Store under an inert atmosphere.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 7681-82-5:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: 1.3 mbar @ 767 deg
Viscosity: Not available.
Boiling Point: 1300 deg C @ 760.00mm Hg
Freezing/Melting Point: 661 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature:
Solubility in water: 1790 G/L (20C)
Specific Gravity/Density: 3.6670g/cm3
Molecular Formula: INa
Molecular Weight: 149.89
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, light, moisture, exposure to air, contact
with water, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, hydrogen iodide, sodium oxide,
iodine.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7681-82-5: WB6475000
LD50/LC50:
CAS# 7681-82-5: Draize test, rabbit, eye: 100 mg/24H Moderate;
Draize test, rabbit, skin: 500 mg/24H Moderate; Oral, mouse: LD50 =
1000 mg/kg; Oral, rat: LD50 = 4340 mg/kg.
Carcinogenicity:
Sodium Iodide -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 7681-82-5: 1
Canada
CAS# 7681-82-5 is listed on Canada's DSL List.
CAS# 7681-82-5 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7681-82-5 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 11/16/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Venfloc 2000, polyaluminium chloride solution, Morton material
| 0-01-1 |
|
Venfloc 1143, polyacrylamide powder, Morton material
| 9003-05-8 |
|
Sodium Chloride, Reagent ACS (Crystals), 99+% (Titr.)
| 7647-14-5 |
|
(1S)-1-(2,5-Dimethoxy-2,5-dihydrofuran-2-yl)ethanol, 98%
| 33647-67-5 |
|
Sodiumborohydride, powder, 98+%, Morton material - 250 gm !!!Bulk
| 16940-66-2 |
|
Propyl formate, 96+%
| 110-74-7 |
|
2,6-Dichloro-5-Fluoro-3-Pyridinecarbonitrile, 95%
| 0-01-1 |
|
3-Methyl-1-Pentanol
| 589-35-5 |
|
Citric acid, trisodium salt dihydrate, 99%
| 6132-04-3 |
|
Sodium hexanitrocobaltate(III)
| 13600-98-1 |
|
(S)-(-)-Indoline-2-carboxylic acid, 98%
| 79815-20-6 |
|
Triallyl-s-triazine-2,4,6(1H,3H,5H)-trione, 98%
| 1025-15-6 |
|
Sodium Cyanide, Reagent ACS (Granular), 95+% (Titr.)
| 143-33-9 |
|
Tetramethylene-d8 sulfone, 99+ atom% D
| 0-01-1 |
|
4-Bromo-1-butene, 98+% (GC)
| 5162-44-7 |
|
2-Bromo-4,5-dimethoxybenzyl alcohol, 98%
| 54370-00-2 |
|
Bisphenol A Dimethylether, 98%
| 1568-83-8 |
|
Sodium dichromate dihydrate, 99%
| 7789-12-0 |
|
2-Bromo-5-Nitrobenzoic Acid
| 943-14-6 |
|
Sodium fluoride, p.a.
| 7681-49-4 |
|
2-Methylformanilide, 98%
| 94-69-9 |
|
Formic acid, sodium salt
| 141-53-7 |
|
Sodium hydrosulfide hydrate, flakes, 68-72%
| 7732-18-5 |
|
Benzophenone Oxime, 98%
| 574-66-3 |
|
Sodium Hydrosulfite
| 7775-14-6 |
|
(+)-cis, trans-Abscisic acid, 99%
| 21293-29-8 |
|
Sodium Hypophosphite Monohydrate, 99%
| 10039-56-2 |
|
Sodium Iodate, Reagent (Powder), 99% (Titr.)
| 7681-55-2 |
|
(S)-N-Carbobenzyloxy-4-Amino-2-Hydroxybutyric Acid, 96%
| 40371-50-4 |
|
Ipriflavone, 99%
| 35212-22-7 |
|
Methyl-6-O-(N-Heptylcarbamoyl)-alpha-D-Glucopyranoside, 99%
| 115457-83-5 |
|
Egg Yolk IgY purification kit
| 0-01-1 |
|
Sodium Iodide, U.S.P./N.F. (Granular), 99% (Titr.)
| 7681-82-5 |
|
Sodium D,L-Lactate,60 wt% Solution in Water
| 72-17-3 |
|
Ampicillin Sodium Salt
| 69-52-3 |
|
Sodium metabisulfite, reagent ACS, 97+%
| 7446-09-5 |
|
Sodium metasilicate, nonahydrate
| 6834-92-0 |
|
Sheep IgG purification kit
| 0-01-1 |
|
Sodium Methoxide, Anhydrous Powder
| 124-41-4 |
|
Methyl 2-Bromo-5-Nitrobenzoic Acid
| 6942-36-5 |
|
1,1,3,5,5-Pentaphenyl-1,3,5-Trimethyltrisiloxane
| 3390-61-2 |
|
2-Amino-2-Indanecarboxylic Acid
| 27473-62-7 |
|
Sodium Nitrite, reagent ACS (crystals), 97+% (titr.)
| 7632-00-0 |
|
Sodium orthovanadate, 99%, - 60 mesh
| 13721-39-6 |
|
3-(2-Naphthyl)-D-Alanine, 99%
| 76985-09-6 |
|
3-[2-(2-Aminoethylamino)ethylamino]propyl-trimethoxysilane, tech.
| 35141-30-1 |
|
Sodium oxalate, p.a.
| 62-76-0 |
|
Sodium periodate, reagent acs
| 7790-28-5 |
|
(-)-(1R,2S)-2-Amino-1-Cyclopentanecarboxylic Acid
| 0-01-1 |
|
Aniline
| 62-53-3 |
|
|